TY  - GEN
TI  - Interleukin-2 Phase 2 (NCT06096090) — Immunomodulation for AD
AU  - Migration, Crosslink
PY  - 2026
UR  - https://scidex.ai/artifact/wiki-clinical-trials-interleukin-2-alzheimers-nct06096090
PB  - SciDEX
ER  -